BriaCell Therapeutics Corp. (NASDAQ:BCTXW – Get Free Report)’s share price fell 11.4% on Thursday . The stock traded as low as $0.12 and last traded at $0.15. 196,944 shares traded hands during mid-day trading, an increase of 77% from the average session volume of 111,154 shares. The stock had previously closed at $0.17.
BriaCell Therapeutics Stock Performance
The stock has a 50-day moving average of $0.31 and a two-hundred day moving average of $0.27.
About BriaCell Therapeutics
BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers.
Featured Articles
- Five stocks we like better than BriaCell Therapeutics
- Profitably Trade Stocks at 52-Week Highs
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- Investing in Commodities: What Are They? How to Invest in Them
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- Ride Out The Recession With These Dividend Kings
- MarketBeat Week in Review – 01/13 – 01/17
Receive News & Ratings for BriaCell Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BriaCell Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
